Investigative Editorial
The Ozempic Illusion
Ozempic is not registered in Nigeria, yet sellers demand millions for products that are often relabeled generics.
Investigative Editorial
Ozempic is not registered in Nigeria, yet sellers demand millions for products that are often relabeled generics.
Narrative
Ozempic’s absence from official registries has not stopped sellers from claiming exclusive access. This editorial documents the price gouging, the misinformation, and the safer alternatives that do exist.
Key facts
Evidence Highlights
Listings show extreme markups.
No registration record found.
Victims report inconsistent packaging.
Scam Timeline
Sellers frame access as exclusive.
Generic semaglutide repackaged.
Markups reach 10-100x.
Spot Fakes
Alternatives
Learn about verified treatment options.